Stay updated on DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial
Sign up to get notified when there's something new on the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page.

Latest updates to the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page
- Check3 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision: v3.4.3 replaces the previous v3.4.2 on the page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.4.2 was added and the lapse-in-funding notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check46 days agoChange DetectedA site-wide notice about government funding status and NIH Clinical Center operations was added. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check53 days agoChange DetectedMinor UI and metadata updates were made: a glossary option was added and labels related to QC updates and the revision/version string were adjusted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check89 days agoChange DetectedA new revision note 'Revision: v3.3.3' has been added, and the HHS Vulnerability Disclosure and Revision: v3.3.2 items were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DA-EPOCH-R+Nivolumab in Rearranged HGBL Clinical Trial page.